Wanbury Ltd reported a significant jump in consolidated net profit to Rs 66.14 crore for FY 2025-26, up from Rs 30.53 crore in the prior year. Revenue grew to Rs 650.27 crore, driven by robust API segment growth and new domestic product launches like Wanbury C RED. The company also successfully implemented SAP S/4 HANA to enhance operational efficiency. While financial health has improved, investors should note the company's Rs 215.45 crore term debt and past regulatory compliance issues related to filing timelines.
Wanbury Ltd Reports Strong FY 2025-26 Financials
Consolidated Net Profit: Rs 66.14 crore
Revenue from Operations: Rs 650.27 crore
Reader Takeaway: Strong profit growth and operational efficiency gains are tempered by significant term debt and past compliance lapses.
What just happened
Wanbury Ltd delivered a strong performance for FY 2025-26, more than doubling its net profit to Rs 66.14 crore compared to Rs 30.53 crore in the previous fiscal. Revenue from operations climbed to Rs 650.27 crore from Rs 599.51 crore. The API segment was a major contributor, recording 8% growth, with exports driving 80% of segment income. Additionally, the company successfully launched 'Wanbury C RED' and new pediatric products under the 'Coriminic' brand.
Why this matters
The company’s operational focus is shifting toward higher-margin domestic formulations while maintaining its API export strength. The successful go-live of the SAP S/4 HANA ERP system on October 3, 2025, signals a push for better data-driven decision-making. Furthermore, the clearing of audits by Australia’s TGA and South Korea’s MFDS demonstrates that its manufacturing facilities meet stringent global regulatory standards.
Corporate Governance and Management
The Board has recommended re-appointing Mr. Mohan Kumar Rayana as Whole-time Director for a five-year term ending in 2031. This move is subject to shareholder approval due to age-related requirements. The company also appointed M/s. ABK & Associates as Cost Auditor for FY 2026-27.
Risks to watch
Investors should monitor the company's debt profile, as Rs 215.45 crore in term debt remains a pressure point. While management has initiated a deleveraging program, interest rate fluctuations could impact profitability. Additionally, the company faced past penalties from BSE and NSE regarding board composition and timely filings, which shareholders should note as a governance watch point.
What to track next
Watch for the contribution of new product launches to domestic margins and updates on the ongoing deleveraging progress to see how effectively the company manages its debt burden in the coming quarters.